hämostaseologie
130090;130265;140300
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Hämostaseologie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
Aims and Scope
Editorial Board
German National License
Authors
Instructions for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Collections
HAMO Women
About Women in Medicine
Open Access
GTH
GTH News
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
Issues
Current Issue
Free Sample Issue (01/2023)
Related Journals
Thrombosis and Haemostasis
International Journal of Angiology
Seminars in Thrombosis and Hemostasis
The Thoracic and Cardiovascular Surgeon
The Thoracic and Cardiovascular Surgeon Reports
TH Open
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
Y
Z
Ú
Ć
Š
Abendroth, A
Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance – successful treatment with lenalidomide and dexamethasone
Aeschbacher, S
Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation
Agosti, M
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Aguiriano-Moser, V
The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes
Akhmedov, A
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota
Alberio, L
Evaluation of different processing methods to label platelets for in vivo studies
Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Epinephrine enhances platelet aggregation at the expense of procoagulant activity
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Alessi, MC
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Evolution of platelet phenotype during SARS-CoV-2 infection
Alexander, WA
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Aliotta, A
Evaluation of different processing methods to label platelets for in vivo studies
Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy
Epinephrine enhances platelet aggregation at the expense of procoagulant activity
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
Allardet-Servent, J
Evolution of platelet phenotype during SARS-CoV-2 infection
Al-Sabbagh, A
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Althaus, K
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Amrane, R
Modelization the impact of antithrombotic agents on pancreatic tumoral micro-environment.
Aggressiveness of breast cancer cells is related with tissue factor expression and procoagulant activity.
Anderle, T
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Andersson, S
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Andreozzi, V
A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII
Andresen, F
Next-generation sequencing identified different types of Hermansky-Pudlak syndrome associated with phenotype variability
Auge, F
Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
Auinger, M
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Ay, C
Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
Growth differentiation factor-15 predicts major cardiac adverse events and all-cause mortality in patients with atrial fibrillation
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Azar, W
Characterization of rFIX fusion proteins enabling subcutaneous administration
Bacher, C
Hepatic Disorders Contribute to Platelet Dysfunction
Bacher, M
In vitro characterization of K5A and K5R variants of Factor IX
Bakchoul, T
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Ballerstädt, N
Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue
Barco, S
Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.
The Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry: background and rationale.
Baumann, J
Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer
Beer, JH
Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota
Beier, R
Causes of Acquired von Willebrands Disease Type II in Pediatric Patients. Cases and literature review.
Bendella, H
Assessment of the anticoagulant effect of direct oral anticoagulants (DOACs) in patients needing immediate management during emergency procedures
Bender, M
Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer
Light-induced ion influx triggers megakaryocyte polarization
Bernot, D
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Evolution of platelet phenotype during SARS-CoV-2 infection
Bertaggia Calderara, D
Evaluation of different processing methods to label platelets for in vivo studies
Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy
Epinephrine enhances platelet aggregation at the expense of procoagulant activity
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
Bertschi, DA
Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation
Bianco, AM
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Bidlingmaier, C
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
Biffi, A
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Binder, M
A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)
Binder, NB
Heparinase treatment to remove the inhibitory heparin effect on the thrombin generation assay
Use of a Universal Calibrator for Direct FXa inhibitor DOACs
Comparing automated FXIII assays
Birschmann, I
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
Bitzer, M
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Block, AC
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Block, H
Examination of the Rac-modulator ArhGAP15 in platelet activation.
Bobek, I
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Bock, H
Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets
Bockel, S
Performance evaluation of the BIOPHEN chromogenic test for Factor XIII activity on the Cobas c502 System
Böddeker, C
Impact of osteopontin on platelet adhesion and activation in intraluminal thrombus formation and abdominal aortic aneurysm progression
Bode, C
Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.
Boeckelmann, D
Next-generation sequencing identified different types of Hermansky-Pudlak syndrome associated with phenotype variability
Boggio, L
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Boireau, W
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Bomke, B
Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance – successful treatment with lenalidomide and dexamethasone
Bonanad, S
A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII
Bonetti, NR
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota
Bönig, H
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Bönigk, H
Application of the STG-Bleedscreen assay in clinical routine
Bontekoe, E
A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay
Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder
Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
Bonzo, D
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Bordet, JC
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Borel-Derlon, A
Safety and efficacy of a high-purity plasma derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for joint bleeding: results from a post-marketing study
Safety and efficacy of a high-purity plasma-derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for gastrointestinal bleeding: results from a post-marketing study
Bortoluzzi, S
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Bösmüller, H
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Bottega, R
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Bourgeois, O
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Bovet, C
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Bradacova, P
Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
Brandenburger, C
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Brehm, MA
Characterization of activity and cleavage of von Willebrand disease type 2B variants
Brinkkoetter, PT
Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab
Brouns, S
Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation
Buchtele, N
Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
Budde, U
Characterization of activity and cleavage of von Willebrand disease type 2B variants
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF
Buresch, L
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Burlina, A
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Buxhofer-Ausch, V
Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab
Cabantous, S
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Cadranel, J
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Camici, GG
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota
Canault, M
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Cao, YW
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Cappenberg, A
Examination of the Rac-modulator ArhGAP15 in platelet activation.
Caspers, M
Assessment of the anticoagulant effect of direct oral anticoagulants (DOACs) in patients needing immediate management during emergency procedures
Castaman, G
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Cerletti, C
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
Cervenak, L
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Chang, T
An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database
Chasakova, K
The occurrence of trombocythopathy in CLL patients treated with Ibrutinib
Chollet, F
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Chowdary, P
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Claar, P
Characterization of rFIX fusion proteins enabling subcutaneous administration
In vitro characterization of K5A and K5R variants of Factor IX
Conen, D
Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation
Constancias, F
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota
Coppens, M
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Corsi, G
The Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry: background and rationale.
Corsi, GP
Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.
Crettaz, D
Evaluation of different processing methods to label platelets for in vivo studies
Csuka, D
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Curth, U
von Willebrand factor (vWF) significantly modifies the sedimentation profile of FVIII-containing immune complexes (FVIII-IC) based on the type of anti-FVIII antibodies
Daravath, B
Hepatic Disorders Contribute to Platelet Dysfunction
Daufenbach, J
The Innovative Factor VIII Molecules HAT and HAT RI Overcome Impairments of Hemophilia A Therapy
De Curtis, A
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
De Ford, C
An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database
de Gaetano, G
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
de la Salle, H
Severity of Transfusion-Related Acute Lung Injury in mice expressing human FcgRIIA is determined by platelet-released serotonin
de Maistre, E
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Dharavath, B
Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
Dieter, Jr
Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder
Dieter, R
Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder
Dimopoulos, MA
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Dixer, B
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Djambas Khayat, C
Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency
Djedidi - Amrane, R
Cancer cell-derived microparticles expressing tissue factor have pivotal role on the procoagulant shift of endothelial cells
Domanovits, H
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
Donati, MB
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
Donner, L
The role of platelet mitochondrial function for platelet mediated Aβ40 aggregation
Dreier, J
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
Dubois, C
Evolution of platelet phenotype during SARS-CoV-2 infection
Ducore, J
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Dunoyer-Geindre, S
Insight into the role of miR-223-3p in regulating platelet reactivity
D’Souza, F
Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Eberl, W
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
Eckly, A
Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research
Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for seven days, with or without Intercept pathogen reduction
Ehrenberg, A
Impact of osteopontin on platelet adhesion and activation in intraluminal thrombus formation and abdominal aortic aneurysm progression
Eichler, H
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Elabbadi, A
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Elalamy, I
International Myeloma Working Group (IMWG) score accuracy in multiple myeloma patients: need for action
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
Elie-Caille, C
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
El Mdawar, M-B
Severity of Transfusion-Related Acute Lung Injury in mice expressing human FcgRIIA is determined by platelet-released serotonin
Elvers, M
Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets
The role of platelet mitochondrial function for platelet mediated Aβ40 aggregation
Impact of osteopontin on platelet adhesion and activation in intraluminal thrombus formation and abdominal aortic aneurysm progression
Elwakiel, A
Factor Xa and factor IIa inhibitors differentially regulate inflammation in myocardial ischemia reperfusion injury
Engelmaier, A
Robust and selective chromogenic measurement of factor VIII activity with an antibody-based factor VIII chromogenic assay
Engelmann, B
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Escobar, M
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Escuriola-Ettinghausen, C
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Escuriola Ettingshausen, C
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
Falaise, C
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Faleschini, M
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
Faletra, F
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Fareed, J
Implementation of Direct Oral Anticoagulant (DOAC) Perioperative Interruption and Interval evaluation of the DOASENSE Dipstick performance
A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay
Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder
Hepatic Disorders Contribute to Platelet Dysfunction
Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
Quantification of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics.
Farooqui, A
Hepatic Disorders Contribute to Platelet Dysfunction
Farto, M
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Fatima, S
Factor Xa and factor IIa inhibitors differentially regulate inflammation in myocardial ischemia reperfusion injury
Feige, T
The role of platelet mitochondrial function for platelet mediated Aβ40 aggregation
Fels, S
Next-generation sequencing identified different types of Hermansky-Pudlak syndrome associated with phenotype variability
Ferrand, N
Aggressiveness of breast cancer cells is related with tissue factor expression and procoagulant activity.
Fillitz, M
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Fischer, B
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
Fischer, J
Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance – successful treatment with lenalidomide and dexamethasone
Fischer, R
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Flasch, T
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Flieder, T
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
Fontana, G
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
Fontana, P
Insight into the role of miR-223-3p in regulating platelet reactivity
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Förhécz, Z
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Fraga, M
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
Freiburg, C
The role of platelet mitochondrial function for platelet mediated Aβ40 aggregation
Freund, M
Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research
Freyer, C
Diagnosis of inherited platelet disorders: comparison between immunofluorescence analysis on the blood smear and genetic testing
Fritz, S
Enhanced prothrombotic state in patients with severe COVID-19
Gabelli, M
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Gachet, C
Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research
Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for seven days, with or without Intercept pathogen reduction
Severity of Transfusion-Related Acute Lung Injury in mice expressing human FcgRIIA is determined by platelet-released serotonin
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice
Gadi, I
Factor Xa and factor IIa inhibitors differentially regulate inflammation in myocardial ischemia reperfusion injury
Gál, J
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Gallistl, S
The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes
Gao, S
Light-induced ion influx triggers megakaryocyte polarization
Garcia, A
Insight into the role of miR-223-3p in regulating platelet reactivity
García Chavez, J
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Garderet, L
International Myeloma Working Group (IMWG) score accuracy in multiple myeloma patients: need for action
Gawaz, M
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Gebhart, H
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Gebhart, J
Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
Geiter, S
Use of a Universal Calibrator for Direct FXa inhibitor DOACs
George, M
Hepatic Disorders Contribute to Platelet Dysfunction
Georgiev, P
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Gerber, B
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Gerotziafas, G
Modelization the impact of antithrombotic agents on pancreatic tumoral micro-environment.
Aggressiveness of breast cancer cells is related with tissue factor expression and procoagulant activity.
International Myeloma Working Group (IMWG) score accuracy in multiple myeloma patients: need for action
Prolonged chemotherapeutic stress is accompanied by an aggressive and singular vascularization process with a high thrombogenic potential in Colorectal Cancer
Differences in the coagulation profile in women with mild and severe eclampsia
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
Cancer cell-derived microparticles expressing tissue factor have pivotal role on the procoagulant shift of endothelial cells
Gialluisi, A
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
Gianfagna, F
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
Giangregorio, T
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
Giermasz, A
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
Glonnegger, H
Next-generation sequencing identified different types of Hermansky-Pudlak syndrome associated with phenotype variability
Gniadek, T
Implementation of Direct Oral Anticoagulant (DOAC) Perioperative Interruption and Interval evaluation of the DOASENSE Dipstick performance
Gobbato, S
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota
Goldmann, G
A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII
Goldstein, J
Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder
Gomez, E
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
Gopcsa, L
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Gottstein, S
Monitoring pain and joint health in patients with haemophilia
Goudemand, J
Safety and efficacy of a high-purity plasma derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for joint bleeding: results from a post-marketing study
Safety and efficacy of a high-purity plasma-derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for gastrointestinal bleeding: results from a post-marketing study
Gowda, LS
Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency
Graf, L
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Granziera, S
Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.
Granzow, N
Monitoring pain and joint health in patients with haemophilia
Greimel, T
The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes
Greinacher, A
Diagnosis of inherited platelet disorders: comparison between immunofluorescence analysis on the blood smear and genetic testing
In-vivo model to assess platelet age in humans: during increased platelet turnover large and small platelets are produced simultaneously
Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer
Antibodies protect platelet damage by pneumolysin
Gremer, L
Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets
Gritsch, H
Heparinase treatment to remove the inhibitory heparin effect on the thrombin generation assay
Groß, HJ
Performance evaluation of the BIOPHEN chromogenic test for Factor XIII activity on the Cobas c502 System
Großschopf-Abele, K
Robust and selective chromogenic measurement of factor VIII activity with an antibody-based factor VIII chromogenic assay
Grotto, P
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Grube, M
Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF
Grünewald, T
Enhanced prothrombotic state in patients with severe COVID-19
Gummert, J
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Gupta, A
LMWH prevents platelet and extracellular vesicle mediated thrombo-inflammation
Gut, R
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
Haas, D
Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for seven days, with or without Intercept pathogen reduction
Häberle, H
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Hagedorn, N
Noonon syndrome as unlikely cause of increased bruising in a case of suspected battered child syndrome
Haidl, H
The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes
Haindl, S
Robust and selective chromogenic measurement of factor VIII activity with an antibody-based factor VIII chromogenic assay
Halfon, P
Evolution of platelet phenotype during SARS-CoV-2 infection
Halimeh, S
Causes of Acquired von Willebrands Disease Type II in Pediatric Patients. Cases and literature review.
Hammer, S
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Hammerschmidt, S
Antibodies protect platelet damage by pneumolysin
Handtke, S
In-vivo model to assess platelet age in humans: during increased platelet turnover large and small platelets are produced simultaneously
Antibodies protect platelet damage by pneumolysin
Hansmann, G
Acquired von Willebrand Syndrom (avWS) Typ 2 in children with severe pulmonary arterial hypertension (PAH)
Hardy, C
Characterization of rFIX fusion proteins enabling subcutaneous administration
In vitro characterization of K5A and K5R variants of Factor IX
Hardy, M
Prothrombotic Disturbances of Hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Study
Harenberg, J
Implementation of Direct Oral Anticoagulant (DOAC) Perioperative Interruption and Interval evaluation of the DOASENSE Dipstick performance
Impact of DOAC Dipstick test and relation to plasma and urine concentrations to exclude the presence of clinically relevant concentrations of DOACs in real-life patient setting – study protocol and case reports
Interaction of direct oral anticoagulants and other anticoagulants on DOAC Dipstick test
Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
Hart, C
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF
Haslacher, H
Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
Hechler, B
Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for seven days, with or without Intercept pathogen reduction
Severity of Transfusion-Related Acute Lung Injury in mice expressing human FcgRIIA is determined by platelet-released serotonin
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice
Hecking, M
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Heemskerk, J
Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation
Hegemann, I
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Evaluation of thrombin generation in patients with sickle cell disease in stable disease and sickle cell crises
Heim, V
Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research
Heimerl, S
Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF
Heinken, A
Anticoagulation practice of cancer-associated thrombosis in the outpatient sector of Germany
Henriet, C
Safety and efficacy of a high-purity plasma derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for joint bleeding: results from a post-marketing study
Safety and efficacy of a high-purity plasma-derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for gastrointestinal bleeding: results from a post-marketing study
Herbener, P
The Innovative Factor VIII Molecules HAT and HAT RI Overcome Impairments of Hemophilia A Therapy
Herkner, H
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
Hermans, C
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Herr, W
Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF
Hertfelder, HJ
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Hetjens, S
Interaction of direct oral anticoagulants and other anticoagulants on DOAC Dipstick test
Hezard, N
Evolution of platelet phenotype during SARS-CoV-2 infection
Hlusi, A
Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
Hofer, S
Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
Hoffmann, T
Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance – successful treatment with lenalidomide and dexamethasone
Holle, J
Assessment of the anticoagulant effect of direct oral anticoagulants (DOACs) in patients needing immediate management during emergency procedures
Holstein, K
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Pain status in patients with hemophilia: evaluation of routine pain assessment in an unselected cohort of patients with hemophilia A and B
Holzhauer, S
Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
Hoppenstaedt, D
Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
Hoppensteadt, D
A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay
Hepatic Disorders Contribute to Platelet Dysfunction
Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
Quantification of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics.
Höpting, M
Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF
Ho-Tin-Noé, B
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice
Hoylaerts, MF
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
Hurler, L
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Iacobelli, M
Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
Iacoviello, L
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
Ibing, W
Impact of osteopontin on platelet adhesion and activation in intraluminal thrombus formation and abdominal aortic aneurysm progression
Ibrahim-Kosta, M
Evolution of platelet phenotype during SARS-CoV-2 infection
Iqbal, O
Hepatic Disorders Contribute to Platelet Dysfunction
Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
Isermann, B
Factor Xa and factor IIa inhibitors differentially regulate inflammation in myocardial ischemia reperfusion injury
LMWH prevents platelet and extracellular vesicle mediated thrombo-inflammation
Isola, H
Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research
Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for seven days, with or without Intercept pathogen reduction
Iványi, Z
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Izzi, B
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
Jahn, K
Antibodies protect platelet damage by pneumolysin
Jahnel, J
The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes
Jankowski, M
Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.
Janus-Bell, E
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice
Jensen, N
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Jeske, W
Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
Quantification of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics.
Jiang, B
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Jilma, B
Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
Jiménez-Yuste, V
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Jin, S
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Jin, SL
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Jönsson, F
Severity of Transfusion-Related Acute Lung Injury in mice expressing human FcgRIIA is determined by platelet-released serotonin
Josting, A
Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue
Journeycake, J
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Kajdácsi, E
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Kämpfe, D
Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue
Kampmann, P
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Kathemann, S
Causes of Acquired von Willebrands Disease Type II in Pediatric Patients. Cases and literature review.
Kaufeld, J
Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab
Kemkes-Matthes, B
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Kenet, G
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Kentouch, K
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
Key, NS
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
Kichou, S
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Kistner, S
The Innovative Factor VIII Molecules HAT and HAT RI Overcome Impairments of Hemophilia A Therapy
Kiszel, P
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Klamroth, R
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Monitoring pain and joint health in patients with haemophilia
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
LMWH or DOACs for cancer associated thrombosis (CAT) in daily clinical practice ? – Insights from the GECAT registry
Klauser-Braun, R
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Kletzmayr, J
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Knabbe, C
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
Knöbl, P
Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation
Knöbl, PN
Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab
Knöfler, R
Laboratory phenotype variability in genetically proven von Willebrand disease type 2B
Knoll Machado, S
In vitro characterization of K5A and K5R variants of Factor IX
Knoops, K
Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation
Knüttgen, F
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
Ko, RH
An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database
Koenen, R
Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation
Kohler, TP
Antibodies protect platelet damage by pneumolysin
Kohli, S
Factor Xa and factor IIa inhibitors differentially regulate inflammation in myocardial ischemia reperfusion injury
LMWH prevents platelet and extracellular vesicle mediated thrombo-inflammation
Königs, C
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
Königsbrügge, O
Growth differentiation factor-15 predicts major cardiac adverse events and all-cause mortality in patients with atrial fibrillation
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Konstantinides, SV
Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.
Kouta, A
A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay
Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
Quantification of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics.
Kraemer, R
A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay
Quantification of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics.
Kraemmer, D
Growth differentiation factor-15 predicts major cardiac adverse events and all-cause mortality in patients with atrial fibrillation
Kragh, T
A novel approach to laboratory assessment of platelet von Willebrand factor
Krammer-Steiner, B
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Kranzhöfer, D
Type 2B von Willebrand disease – a rare cause of neonatal thrombocytopenia
Kraushaar, T
In vitro characterization of K5A and K5R variants of Factor IX
Kremer Hovinga, J
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Kremer Hovinga, J-A
Upregulated autophagy in antigen-presenting splenic cells hints at promotion of immune-mediated thrombotic thrombocytopenic purpura (iTTP)
Kretzschmar, A
Anticoagulation practice of cancer-associated thrombosis in the outpatient sector of Germany
Krohn-Grimberghe, M
Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.
Krstic, M
Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab
Krueger, I
Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets
Kruzhkova, I
Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency
Kuebler, P
An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database
Kurnik, K
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII
Kurz, H
Light-induced ion influx triggers megakaryocyte polarization
Lackowa, N
Enhanced prothrombotic state in patients with severe COVID-19
Lakatos, B
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Lambeck, KA
Acquired von Willebrand Syndrom (avWS) Typ 2 in children with severe pulmonary arterial hypertension (PAH)
Lang, I
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Lang, T
Reversal of DOAC in RVV-test on the ClotPro analyzer
Langer, F
Pain status in patients with hemophilia: evaluation of routine pain assessment in an unselected cohort of patients with hemophilia A and B
Larsen, AK
Prolonged chemotherapeutic stress is accompanied by an aggressive and singular vascularization process with a high thrombogenic potential in Colorectal Cancer
Lassel, L
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Lattimore, SU
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
Leblois, T
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Lecompte, T
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Prothrombotic Disturbances of Hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Study
Leebeek, F
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Lefkou, E
Differences in the coagulation profile in women with mild and severe eclampsia
Lehmann, K
Characterization of activity and cleavage of von Willebrand disease type 2B variants
Leinoe, E
Diagnosis of inherited platelet disorders: comparison between immunofluorescence analysis on the blood smear and genetic testing
Leitner, M
Comparing automated FXIII assays
Lenkeit, L
Platelets from patients with MYH9 related disorders are mechanically stiffer
Lenz, A
Next-generation sequencing identified different types of Hermansky-Pudlak syndrome associated with phenotype variability
Lepatan, LM
Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen
Le Roy de Boiseaumarié, B
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Li, Y
Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen
Lia, M
LMWH prevents platelet and extracellular vesicle mediated thrombo-inflammation
Liang, BS
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Liberale, L
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota
Lissitchkov, T
Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Liu, C
Examination of the Rac-modulator ArhGAP15 in platelet activation.
Thrombopoietin levels in sepsis and septic shock - a meta-analysis.
Llusa, M
Heparinase treatment to remove the inhibitory heparin effect on the thrombin generation assay
Lohade, S
Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Lohade, SD
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency
Loosveld, M
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Lorenz, M
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Lovrenčić-Huzjan, A
Impact of DOAC Dipstick test and relation to plasma and urine concentrations to exclude the presence of clinically relevant concentrations of DOACs in real-life patient setting – study protocol and case reports
Lu, Q
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Lucklum, R
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Lüscher, TF
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota
Machacek, J
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Magnacca, S
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
Magnenat, S
Severity of Transfusion-Related Acute Lung Injury in mice expressing human FcgRIIA is determined by platelet-released serotonin
Mahlangu, J
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Maître, B
Severity of Transfusion-Related Acute Lung Injury in mice expressing human FcgRIIA is determined by platelet-released serotonin
Malek, N
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Manceau, JF
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Mancuso, ME
Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen
A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
Mangels, L
Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets
Mangin, P
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice
Marconi, C
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
Margetić, S
Impact of DOAC Dipstick test and relation to plasma and urine concentrations to exclude the presence of clinically relevant concentrations of DOACs in real-life patient setting – study protocol and case reports
Margraf, A
Examination of the Rac-modulator ArhGAP15 in platelet activation.
Thrombopoietin levels in sepsis and septic shock - a meta-analysis.
Marini, I
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Marinoni, M
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Maro, G
A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
Marten, S
Laboratory phenotype variability in genetically proven von Willebrand disease type 2B
Martin, A
Evaluation of different processing methods to label platelets for in vivo studies
Martinez, R
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Marzollo, A
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Massberg, S
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Masszi, T
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Matzdorff, A
A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)
May, M
Anticoagulation practice of cancer-associated thrombosis in the outpatient sector of Germany
Mbemba, E
Modelization the impact of antithrombotic agents on pancreatic tumoral micro-environment.
Aggressiveness of breast cancer cells is related with tissue factor expression and procoagulant activity.
Cancer cell-derived microparticles expressing tissue factor have pivotal role on the procoagulant shift of endothelial cells
Mege, D
Evolution of platelet phenotype during SARS-CoV-2 infection
Mege, JL
Evolution of platelet phenotype during SARS-CoV-2 infection
Mehic, D
Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
Mehrländer, M
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Mei, B
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Meier, O
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Meijer, K
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Meinel, K
The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes
Meisel, H
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Meißner, V
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Meister, S
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Mendez, A
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Menne, J
Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab
Merrelaar, A
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
Metz, LM
Phosphorylation and activation of Pannexin-1 upon platelet activation and thrombus formation
Meyer, O
Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue
A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)
Mező, B
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Miesbach, W
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab
Miesbach, WA
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Mischnik, M
Characterization of rFIX fusion proteins enabling subcutaneous administration
Mischung, C
Noonon syndrome as unlikely cause of increased bruising in a case of suspected battered child syndrome
Mitchell, IS
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Mohebi, D
Anticoagulation practice of cancer-associated thrombosis in the outpatient sector of Germany
Möhnle, P
A novel approach to laboratory assessment of platelet von Willebrand factor
Mohr, G
Robust and selective chromogenic measurement of factor VIII activity with an antibody-based factor VIII chromogenic assay
Mojzisch, A
Characterization of activity and cleavage of von Willebrand disease type 2B variants
Mondorf, W
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Moradpour, D
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
Morange, PE
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Evolution of platelet phenotype during SARS-CoV-2 infection
Morel-Kopp, MC
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
Mourey, G
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Mouriaux, C
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice
Mueller, T
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Mukhin, N
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Müller, B
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
Müller, J
Aptamer-based ex vivo monitoring of thrombin and activated protein C generation on blood outgrowth endothelial cells for individualized assessment of the protein C pathway
Müller, V
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Müller-Plettenberg, B
Safety and efficacy of a high-purity plasma derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for joint bleeding: results from a post-marketing study
Safety and efficacy of a high-purity plasma-derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for gastrointestinal bleeding: results from a post-marketing study
Mullier, F
Prothrombotic Disturbances of Hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Study
Muret, C
Evaluation of different processing methods to label platelets for in vivo studies
Naas, S
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Nagao, A
Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen
Nagel, G
Light-induced ion influx triggers megakaryocyte polarization
Nagler, M
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Nagy, M
Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation
Nagy, Z
Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Negrier, C
An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database
Négrier, C
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Nemani, A
Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.
Nestler, P
Platelets from patients with MYH9 related disorders are mechanically stiffer
Neudorf, U
Causes of Acquired von Willebrands Disease Type II in Pediatric Patients. Cases and literature review.
Ní Áinle, F
Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation
Nicoletti, TF
Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.
Nimmerjahn, F
A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)
Nimtz-Talaska, A
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Nolli, S
Insight into the role of miR-223-3p in regulating platelet reactivity
Nolte, MW
Characterization of rFIX fusion proteins enabling subcutaneous administration
In vitro characterization of K5A and K5R variants of Factor IX
Nopp, S
Growth differentiation factor-15 predicts major cardiac adverse events and all-cause mortality in patients with atrial fibrillation
Noris, P
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Núñez, R
A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII
Obser, T
Characterization of activity and cleavage of von Willebrand disease type 2B variants
Oldenburg, J
Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Aptamer-based ex vivo monitoring of thrombin and activated protein C generation on blood outgrowth endothelial cells for individualized assessment of the protein C pathway
Oleshko, O
von Willebrand factor (vWF) significantly modifies the sedimentation profile of FVIII-containing immune complexes (FVIII-IC) based on the type of anti-FVIII antibodies
Olive, D
Evolution of platelet phenotype during SARS-CoV-2 infection
Olivieri, M
Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
Orlandi, S
Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort
Oseev, A
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Osswald, S
Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation
Ott, HW
A novel approach to laboratory assessment of platelet von Willebrand factor
Otto, O
Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer
Ozelo, M
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Pabinger, I
Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen
Growth differentiation factor-15 predicts major cardiac adverse events and all-cause mortality in patients with atrial fibrillation
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Palankar, R
Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer
Antibodies protect platelet damage by pneumolysin
Panicot-Dubois, L
Evolution of platelet phenotype during SARS-CoV-2 infection
Papa, N
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
Papageorgiou, C
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Papageorgiou, L
International Myeloma Working Group (IMWG) score accuracy in multiple myeloma patients: need for action
Differences in the coagulation profile in women with mild and severe eclampsia
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
Papajík, T
The occurrence of trombocythopathy in CLL patients treated with Ibrutinib
Paric, L
Comparing automated FXIII assays
Parrot, A
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Pasi, KJ
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Pasterk, L
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota
Pastore, A
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Pavlova, A
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Type 2B von Willebrand disease – a rare cause of neonatal thrombocytopenia
Paz Rios, LH
Implementation of Direct Oral Anticoagulant (DOAC) Perioperative Interruption and Interval evaluation of the DOASENSE Dipstick performance
Pecci, A
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.
Peine, S
Characterization of activity and cleavage of von Willebrand disease type 2B variants
Peiretti, F
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Pekrul, I
A novel approach to laboratory assessment of platelet von Willebrand factor
Pelzl, L
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Persico, I
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Pestel, S
Characterization of rFIX fusion proteins enabling subcutaneous administration
In vitro characterization of K5A and K5R variants of Factor IX
Petros, S
Enhanced prothrombotic state in patients with severe COVID-19
Peyvandi, F
Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency
Pezeshkpoor, B
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Pfrepper, C
Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
Pialloux, G
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Pillny, C
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Pink, M
Performance evaluation of the BIOPHEN chromogenic test for Factor XIII activity on the Cobas c502 System
Pipe, SW
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Plath, M
Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue
Poggi, M
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Pohl, S
The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes
Pollich, C
LMWH or DOACs for cancer associated thrombosis (CAT) in daily clinical practice ? – Insights from the GECAT registry
Poloskey, S
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Pongérard, A
Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research
Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for seven days, with or without Intercept pathogen reduction
Ponnuswamy, P
In vitro characterization of K5A and K5R variants of Factor IX
Pötzsch, B
Aptamer-based ex vivo monitoring of thrombin and activated protein C generation on blood outgrowth endothelial cells for individualized assessment of the protein C pathway
Poveda, JL
A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII
Proamer, F
Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research
Prochazkova, J
Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
Prohászka, ZZ
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Prudent, M
Evaluation of different processing methods to label platelets for in vivo studies
Psaltopoulou, T
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Puceat, M
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Pugin, B
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota
Qin, D
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Qiu, Z
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Quehenberger, P
Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation
Quon, D
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Ragni, MV
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Rangarajan, S
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Rao, BQ
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Rath, A
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Rath, D
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Ravanat, C
Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research
Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for seven days, with or without Intercept pathogen reduction
Receveur, N
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice
Recht, M
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
Reiner, MF
Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation
Reinhardt, D
Causes of Acquired von Willebrands Disease Type II in Pediatric Patients. Cases and literature review.
Reiser, J
Cooperation of platelet beta1 and beta3 integrins in the arrest of inflammatory bleeding in mice
Reiser, M
Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue
Reményi, P
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Remy-Martin, F
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Reny, JL
Insight into the role of miR-223-3p in regulating platelet reactivity
Reschke, M
Causes of Acquired von Willebrands Disease Type II in Pediatric Patients. Cases and literature review.
Noonon syndrome as unlikely cause of increased bruising in a case of suspected battered child syndrome
Réti, M
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Richter, H
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Riedesel, J
Characterization of rFIX fusion proteins enabling subcutaneous administration
Rieke, M
Reversal of DOAC in RVV-test on the ClotPro analyzer
Riess, H
Anticoagulation practice of cancer-associated thrombosis in the outpatient sector of Germany
LMWH or DOACs for cancer associated thrombosis (CAT) in daily clinical practice ? – Insights from the GECAT registry
Rivera, J
Diagnosis of inherited platelet disorders: comparison between immunofluorescence analysis on the blood smear and genetic testing
Robson, S
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Robustelli, G
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Röder, J
In vitro characterization of K5A and K5R variants of Factor IX
Roesch, A
smart medication DocuScan: GSAV-compliant documentation of hemophilia preparations for pharmacies, doctors, treatment centers and patients
Roeschl, S
Assessment of the anticoagulant effect of direct oral anticoagulants (DOACs) in patients needing immediate management during emergency procedures
Rosenberger, P
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Rossner, M
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Rouleau, A
Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations
Rousseau, A
Differences in the coagulation profile in women with mild and severe eclampsia
Rudtke, C
Performance evaluation of the BIOPHEN chromogenic test for Factor XIII activity on the Cobas c502 System
Rudwill, F
Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research
Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for seven days, with or without Intercept pathogen reduction
Rühl, H
Aptamer-based ex vivo monitoring of thrombin and activated protein C generation on blood outgrowth endothelial cells for individualized assessment of the protein C pathway
Rummel, MJ
A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)
Rutishauser, J
Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation
Ruzicka, G
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Sabbah, M
Modelization the impact of antithrombotic agents on pancreatic tumoral micro-environment.
Aggressiveness of breast cancer cells is related with tissue factor expression and procoagulant activity.
Cancer cell-derived microparticles expressing tissue factor have pivotal role on the procoagulant shift of endothelial cells
Sacco, C
Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.
Sachs, L
Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer
Saeedi, SS
Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation
Saeedi Saravi, SS
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota
Säemann, M
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Saith, SE
Incidence of Thrombosis and Associated Risk Factors in Hospitalized COVID-19 Patients in a New York City Hospital System
Sanabria, F
An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database
Sangalli-Baruffaldi, J
Evaluation of thrombin generation in patients with sickle cell disease in stable disease and sickle cell crises
Santoro, C
A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
Santos, S
A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII
Sauer, T
A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)
Saultier, P
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Saut, N
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Savoia, A
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Sawyer, EK
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Schaller, M
Upregulated autophagy in antigen-presenting splenic cells hints at promotion of immune-mediated thrombotic thrombocytopenic purpura (iTTP)
Scharf, R
Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance – successful treatment with lenalidomide and dexamethasone
Schellong, S
Anticoagulation practice of cancer-associated thrombosis in the outpatient sector of Germany
Schelzig, H
Impact of osteopontin on platelet adhesion and activation in intraluminal thrombus formation and abdominal aortic aneurysm progression
Schlag, R
Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue
Schlagenhauf, A
The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes
Schmaldienst, S
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Schmidt, A
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Schmidt-Supprian, M
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Schmitt, C
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Schmoldt, D
smart medication DocuScan: GSAV-compliant documentation of hemophilia preparations for pharmacies, doctors, treatment centers and patients
Schneider, H
Type 2B von Willebrand disease – a rare cause of neonatal thrombocytopenia
Schneppenheim, R
Characterization of activity and cleavage of von Willebrand disease type 2B variants
Schneppenheim, S
Characterization of activity and cleavage of von Willebrand disease type 2B variants
Schoenichen, C
Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation
Schoergenhofer, C
Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Schön, I
Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Schön, K
Characterization of rFIX fusion proteins enabling subcutaneous administration
Schörgenhofer, C
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
Schramm, T
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
Schröder, G
Pain status in patients with hemophilia: evaluation of routine pain assessment in an unselected cohort of patients with hemophilia A and B
Schulte, J
Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.
Schutgens, R
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Schüttrumpf, J
The Innovative Factor VIII Molecules HAT and HAT RI Overcome Impairments of Hemophilia A Therapy
Schwaeble, J
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Schwameis, M
Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
Schwartz, B
Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency
Schwarz, N
Aptamer-based ex vivo monitoring of thrombin and activated protein C generation on blood outgrowth endothelial cells for individualized assessment of the protein C pathway
Sebastian, T
The Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry: background and rationale.
Seifert, W
Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen
Seifried, E
AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years
Sergentanis, T
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Seri, M
Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
Severin, K
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Seyfert-Brandt, W
Characterization of rFIX fusion proteins enabling subcutaneous administration
Shahzad, K
Factor Xa and factor IIa inhibitors differentially regulate inflammation in myocardial ischemia reperfusion injury
Shang, A
An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database
Shanmukhaiah, C
Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors
Shi, HP
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Siddiqui, F
A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay
Hepatic Disorders Contribute to Platelet Dysfunction
Siegemund, A
Application of the STG-Bleedscreen assay in clinical routine
Enhanced prothrombotic state in patients with severe COVID-19
Siegemund, T
Application of the STG-Bleedscreen assay in clinical routine
Enhanced prothrombotic state in patients with severe COVID-19
Sigmund, M
Performance evaluation of the BIOPHEN chromogenic test for Factor XIII activity on the Cobas c502 System
Simoncini, D
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms
Singh, K
LMWH prevents platelet and extracellular vesicle mediated thrombo-inflammation
Sinkovits, G
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Sinn, M
LMWH or DOACs for cancer associated thrombosis (CAT) in daily clinical practice ? – Insights from the GECAT registry
Skoumalova, A
Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Slavik, L
Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
Slavík, L
The occurrence of trombocythopathy in CLL patients treated with Ibrutinib
SMontague, S
Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation
Sobotta, F
Next-generation sequencing identified different types of Hermansky-Pudlak syndrome associated with phenotype variability
Soehnlein, O
Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation
Solomon, C
Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency
Sommerer, P
A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
Souza, FD
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency
Spannagl, M
A novel approach to laboratory assessment of platelet von Willebrand factor
Spiel, A
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Stark-Lorenzen, P
Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue
Starostka, D
The occurrence of trombocythopathy in CLL patients treated with Ibrutinib
Stauch, M
Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue
Staudinger, T
Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation
Steffen, F
Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.
Stepan, H
LMWH prevents platelet and extracellular vesicle mediated thrombo-inflammation
Studt, JD
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Sussebach, C
Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study
Szathmáry, B
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Szlávik, J
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Tafur, AJ
Implementation of Direct Oral Anticoagulant (DOAC) Perioperative Interruption and Interval evaluation of the DOASENSE Dipstick performance
Terpos, E
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Tesanovic, T
A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)
Tetzlaff, M
Pain status in patients with hemophilia: evaluation of routine pain assessment in an unselected cohort of patients with hemophilia A and B
Thakur, M
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Theprungsirikul, P
Incidence of Thrombosis and Associated Risk Factors in Hospitalized COVID-19 Patients in a New York City Hospital System
Thiele, T
In-vivo model to assess platelet age in humans: during increased platelet turnover large and small platelets are produced simultaneously
Thouroude, S
Prolonged chemotherapeutic stress is accompanied by an aggressive and singular vascularization process with a high thrombogenic potential in Colorectal Cancer
Tiebel, O
Laboratory phenotype variability in genetically proven von Willebrand disease type 2B
Tiede, A
Acquired Hemophilia A (AHA) Limits of the Awareness Push in Germany
von Willebrand factor (vWF) significantly modifies the sedimentation profile of FVIII-containing immune complexes (FVIII-IC) based on the type of anti-FVIII antibodies
Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF
Tollnick, M
Reversal of DOAC in RVV-test on the ClotPro analyzer
Tran, H
Modelization the impact of antithrombotic agents on pancreatic tumoral micro-environment.
Trautmann, K
Laboratory phenotype variability in genetically proven von Willebrand disease type 2B
Tschan, M-P
Upregulated autophagy in antigen-presenting splenic cells hints at promotion of immune-mediated thrombotic thrombocytopenic purpura (iTTP)
Tupin, F
Severity of Transfusion-Related Acute Lung Injury in mice expressing human FcgRIIA is determined by platelet-released serotonin
Turcsanyi, P
The occurrence of trombocythopathy in CLL patients treated with Ibrutinib
Türknetz, M
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
Turpin, M
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Ulehlova, J
Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
Ullrychova, J
Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
Unislawski, V
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Unterberger, M
Use of a Universal Calibrator for Direct FXa inhibitor DOACs
Comparing automated FXIII assays
Urbanová, R
The occurrence of trombocythopathy in CLL patients treated with Ibrutinib
Valerio, L
Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.
The Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry: background and rationale.
Vályi-Nagy, I
Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients
Vandewalle, B
A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII
Vandreden, P
Modelization the impact of antithrombotic agents on pancreatic tumoral micro-environment.
Aggressiveness of breast cancer cells is related with tissue factor expression and procoagulant activity.
International Myeloma Working Group (IMWG) score accuracy in multiple myeloma patients: need for action
Differences in the coagulation profile in women with mild and severe eclampsia
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
Van Dreden, P
Prolonged chemotherapeutic stress is accompanied by an aggressive and singular vascularization process with a high thrombogenic potential in Colorectal Cancer
Cancer cell-derived microparticles expressing tissue factor have pivotal role on the procoagulant shift of endothelial cells
Van Thiel, D
Hepatic Disorders Contribute to Platelet Dysfunction
Veltrup, K
Pain status in patients with hemophilia: evaluation of routine pain assessment in an unselected cohort of patients with hemophilia A and B
Verrel, F
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Vitte, J
Evolution of platelet phenotype during SARS-CoV-2 infection
Voiriot, G
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19
Völker, L
Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab
Vollmer, T
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
Von Agthoven, J
GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
von Bargen, K
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
von der Heyde, E
Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue
von Drygalski, A
Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial
von Mackensen, S
Pain status in patients with hemophilia: evaluation of routine pain assessment in an unselected cohort of patients with hemophilia A and B
von zur Mühlen, C
Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.
Wagenhäuser, M
Impact of osteopontin on platelet adhesion and activation in intraluminal thrombus formation and abdominal aortic aneurysm progression
Wahler, S
Acquired Hemophilia A (AHA) Limits of the Awareness Push in Germany
Walenga, JM
Implementation of Direct Oral Anticoagulant (DOAC) Perioperative Interruption and Interval evaluation of the DOASENSE Dipstick performance
Wang, M
Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study
Wang, YJ
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Watson, S
Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation
Weber, A
Heparinase treatment to remove the inhibitory heparin effect on the thrombin generation assay
Robust and selective chromogenic measurement of factor VIII activity with an antibody-based factor VIII chromogenic assay
Wei, XX
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Weiss, C
Interaction of direct oral anticoagulants and other anticoagulants on DOAC Dipstick test
Wenning, S
Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
Werlen, L
Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation
Wermes, C
Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
Werwitzke, S
von Willebrand factor (vWF) significantly modifies the sedimentation profile of FVIII-containing immune complexes (FVIII-IC) based on the type of anti-FVIII antibodies
Wesche, J
Platelets from patients with MYH9 related disorders are mechanically stiffer
Antibodies protect platelet damage by pneumolysin
Wieland, I
Acquired von Willebrand Syndrom (avWS) Typ 2 in children with severe pulmonary arterial hypertension (PAH)
Wieschhaus, K
Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder
Willbold, D
Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets
Willekens, G
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Winkelmayer, W
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Winterling, K
The Innovative Factor VIII Molecules HAT and HAT RI Overcome Impairments of Hemophilia A Therapy
Wohlrab, M
Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection
Wolff, M
Diagnosis of inherited platelet disorders: comparison between immunofluorescence analysis on the blood smear and genetic testing
In-vivo model to assess platelet age in humans: during increased platelet turnover large and small platelets are produced simultaneously
Wolny, M
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation
Wuillemin, WA
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
Yang, P
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Yang, ZP
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Yao, Y
Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
Yildiz, Y
Characterization of activity and cleavage of von Willebrand disease type 2B variants
Yu-Strzelczyk, J
Light-induced ion influx triggers megakaryocyte polarization
Zane, F
Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.
Zaninetti, C
Diagnosis of inherited platelet disorders: comparison between immunofluorescence analysis on the blood smear and genetic testing
Platelets from patients with MYH9 related disorders are mechanically stiffer
Zarbock, A
Examination of the Rac-modulator ArhGAP15 in platelet activation.
Thrombopoietin levels in sepsis and septic shock - a meta-analysis.
Zekavat, O
Efficacy and Safety of Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Paediatric Patients with Congenital Fibrinogen Deficiency
Zermatten, M
Evaluation of different processing methods to label platelets for in vivo studies
Zermatten, MG
Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy
Epinephrine enhances platelet aggregation at the expense of procoagulant activity
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
Zeymer, U
Current status of anti-thrombotic therapy in patients with atrial fibrillation undergoing PCI. Results of the prospective RIVA-PCI Registry.
Zhang, LC
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Zhang, T
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Zhang, Y
Light-induced ion influx triggers megakaryocyte polarization
Zhou, S
Performance evaluation of the BIOPHEN chromogenic test for Factor XIII activity on the Cobas c502 System
Zhuang, B
Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study
Zieger, B
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
Type 2B von Willebrand disease – a rare cause of neonatal thrombocytopenia
Next-generation sequencing identified different types of Hermansky-Pudlak syndrome associated with phenotype variability
Ziessel, C
Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the mouse circulation. A promising approach to monitor in vivo platelet survival in clinical research
Zittermann, A
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Zivsa, M
Robust and selective chromogenic measurement of factor VIII activity with an antibody-based factor VIII chromogenic assay
Zlabinger, C
Robust and selective chromogenic measurement of factor VIII activity with an antibody-based factor VIII chromogenic assay
Zlamal, J
Platelet activation and apoptosis in COVID-19 infection: data from an observational study
Úlehlová, J
The occurrence of trombocythopathy in CLL patients treated with Ibrutinib
Ćelap, I
Impact of DOAC Dipstick test and relation to plasma and urine concentrations to exclude the presence of clinically relevant concentrations of DOACs in real-life patient setting – study protocol and case reports
Šupraha Goreta, S
Impact of DOAC Dipstick test and relation to plasma and urine concentrations to exclude the presence of clinically relevant concentrations of DOACs in real-life patient setting – study protocol and case reports